The size of the cannabis testing market in the Middle East & Africa was worth USD 79.87 Million in 2022. This value is estimated to grow at a CAGR of 13.1% and will be worth USD 147.81 Million by 2027.
Cannabis a banned for various social and political reasons in most countries since the early 1900s. Many countries are now recognizing the benefits of cannabis for medical purposes and have approved the use of cannabis. The growth of the cannabis testing market in the MEA is majorly driven by factors such as the legalization of medical marijuana, an increase in marijuana labs (particularly in the United States), and increased use of LIMS in marijuana labs, conferences, and discussions. Awareness-raising meetings and workshops are expected to create the need for analytical testing to ensure the safety of human food and the growth of the MEA cannabis testing market.
In the MEA Cannabis Testing Market, highly developed industries and a variety of mature emerging areas are creating various market opportunities. Also, mergers & acquisitions, partnerships, contracts, agreements, new product launches, etc., by key players to gain a competitive edge over other companies can help increase market demand. In addition, the increased demand for medicines and therapeutic cannabis will likely expand market growth during the forecast period.
The high cost of analytical instruments, the presence of alternative technologies, and the lack of skilled professionals are critical factors that are supposed to limit the growth of the MEA Cannabis Testing Market in the future. Proper use of advanced analytical instruments requires relevant experience and knowledge of chromatography, spectroscopy, and PCR. In addition, the lack of awareness of the right technology choice, especially in emerging economies, has created many other indirect costs, increasing the workload and time pressure on researchers. This limits the use of these technically advanced products in the laboratory. Also, the laboratories are expensive to start, and analytical equipment is costly.
This research report on the MEA cannabis testing market has been segmented and sub-segmented into the following categories:
By Testing Procedures:
By Product & Software:
Geographically, the Middle East and African cannabis testing markets are still nascent in this region. However, factors such as the rising number of accidents under the influence of cannabis and its legalization for medical purposes in some parts of the world are expected to increase the growth of this market in the region.
KEY MARKET PLAYERS:
A few of the prominent companies operating in the MEA cannabis testing market profiled in the report are Agilent Technologies, Inc., Shimadzu Corporation, Waters Corporation, PerkinElmer, Inc., AB SCIEX LLC, Millipore Sigma, Restek Corporation, LabLynx, Inc. (U.S.), Steep Hill Labs, Inc., PharmLabs, LLC, SC Laboratories, Inc., Digipath Labs, Inc., CannaSafe Analytics, and Accelerated Technology Laboratories, Inc.
The MEA cannabis testing market size is estimated to be worth USD 147.8 million by 2027.
Factors such as increasing demand for cannabis products, the growing awareness about the importance of cannabis testing, the increasing legalization of cannabis, and the rising trend of self-medication are driving the MEA cannabis testing market.
Eurofins Scientific SE, Steep Hill, Inc., Agilent Technologies, Inc., Shimadzu Corporation, and CannaSafe Analytics are some of the key players in the MEA cannabis testing market.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com